Kezar Life Sciences (KZR) Receives a Buy from TD Cowen

3 days ago · Nov. 12, 2024, 11:05 PM. TD Cowen analyst Phil Nadeau maintained a Buy rating on Kezar Life Sciences (KZR – Research Report) yesterday. The company’s shares closed …

CouponFollow Extension

$0.00
OFF

Kezar Life Sciences Stock Price | KZR Stock Quote, News, And …

1 week from now

On Tuesday morning 10/29/2024 the Kezar Life Sciences Inc Registered Shs share started trading at the price of $0.00. ... Kezar Life Sciences (KZR) Receives a Buy from TD Cowen. …

businessinsider.com

$7.00
OFF

Buy Rating On Kezar Life Sciences Backed By Promising …

1 week from now

Aug. 14, 2024, 04:37 AM. Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Kezar Life Sciences (KZR – Research Report) and keeping the price target at $7.00. Ram …

businessinsider.com

$2.78
OFF

Kezar Life Sciences (KZR) Earnings Date And Reports 2024

1 week from now

2 days ago · Kezar Life Sciences issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$2.78, which beat analysts' consensus estimates of -$3.03 by $0.25. With a trailing …

marketbeat.com

FAQs about Kezar Life Sciences (KZR) Receives a Buy from TD Cowen Coupon?

Does Kezar life sciences (KZR) have a reverse stock split?

(RTTNews) - Kezar Life Sciences, Inc. (KZR), a clinical-stage biotechnology company, Monday announced one-for-ten reverse stock split. This reverse stock split is to regain compliance with the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market. ...

Who owns Kezar Life Sciences Inc KZR?

Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA. View Kezar Life Sciences Inc KZR stock quote prices, financial information, real-time forecasts, and company news from CNN. ...

How much does Kezar life sciences (KZR) earn?

Kezar Life Sciences (NASDAQ:KZR) has a recorded net income of -$101.87 million. KZR has generated -$13.18 earnings per share over the last four quarters. What is Kezar Life Sciences's EPS forecast for next year? Kezar Life Sciences's earnings are expected to grow from ($11.95) per share to ($9.73) per share in the next year. ...

How did Kezar life sciences perform in Q3 2024?

Kezar Life Sciences issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$2.78, which beat analysts' consensus estimates of -$3.03 by $0.25. With a trailing EPS of -$13.18, Kezar Life Sciences' earnings are expected to grow next year, from ($11.95) to ($9.73) per share. ...

Is Kezar Life Sciences a good stock to buy?

The word on The Street in general, suggests a Hold analyst consensus rating for Kezar Life Sciences with a $20.00 average price target. Based on Kezar Life Sciences’ latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $21.55 million. ...

What is the 12-month price forecast for Kezar life sciences (KZR)?

The 12-month stock price forecast is $20.0, which is an increase of 171.37% from the latest price. NEW YORK-- (BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Kezar Life Sciences, Inc. (Nasdaq: KZR) concerning the Company and its directors' and officers' possible v... ...